Web6 mar 2024 · Two large, multicentre, phase 3 trials, JCOG0802/WJOG4607L 1 and CALGB140503, 2 provided evidence that segmentectomy, as a surgical procedure, could be used without compromising oncological therapeutic outcome compared with lobectomy in early stage non-small-cell lung cancer (NSCLC) with a tumour 2 cm or less in size and a … WebJCOG0802/WJOG4607L was a. randomized trial comparing lobectomy and segmentectomy for radiologic invasive lung cancer, and JCOG0804/WJOG4507L was a 1-arm multicenter pro-. spective study for investigating the feasibility of wide wedge resection for radiologically noninvasive lung cancer defined by JCOG0201.
郑慧禹医生的科普号
Web6 mar 2024 · Two large, multicentre, phase 3 trials, JCOG0802/WJOG4607L1 and CALGB140503,2 provided evidence that segmentectomy, as a surgical procedure, could be used without compromising oncological therapeutic outcome compared with lobectomy in early stage non-small-cell lung cancer (NSCLC) with a tumour 2 cm or less in size and a … tina klump go travel
Segmentectomy versus lobectomy in small-sized ... - ScienceDirect
Web29 giu 2024 · Recently, professor Hisao Asamura released the long-term results of the JCOG0802 project in AATS 2024. Segmentectomy had a higher 5-year overall survival … Web26 ago 2024 · Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised ... Web23 apr 2024 · JCOG0802/WJOG4607L was a multi-institutional and intergroup randomised, open-label, phase 3, randomised controlled trial at 70 institutions in Japan (appendix pp 17–18) designed to support the non-inferiority of segmentectomy for overall survival versus lobectomy, the standard of care, in patients with clinical stage IA small-sized (≤2 cm; … baupublikationen